Table 1.
Characteristic | Patients, No. (%)b |
||
---|---|---|---|
Cohort A (n = 3933) | Cohort B (n = 2163) | Cohort C (n = 611) | |
Age, y | |||
18–24 | 252 (6.4) | 130 (6.0) | 71 (11.6) |
25–34 | 805 (20.5) | 391 (18.1) | 147 (24.1) |
35–44 | 978 (24.9) | 541 (25.0) | 140 (22.9) |
45–54 | 1371 (34.9) | 799 (36.9) | 188 (30.8) |
55–64 | 527 (13.4) | 302 (14.0) | 65 (10.6) |
Race/ethnicity | |||
American Indian/Alaska Native/Native Hawaiian | 25 (0.6) | 17 (0.8) | 10 (1.6) |
Asian | 67 (1.7) | 37 (1.7) | 3 (0.5) |
Black/African American | 2601 (66.1) | 2523 (65.3) | 435 (71.2) |
Hispanic/Latino | 266 (6.8) | 175 (8.1) | 39 (6.4) |
White | 974 (24.8) | 522 (24.1) | 124 (20.3) |
Sex | |||
Female | 1086 (27.6) | 639 (29.5) | 178 (29.1) |
Transgender | 27 (0.7) | 7 (0.3) | 3 (0.5) |
Male | 2820 (71.7) | 522 (24.1) | 124 (20.3) |
HIV/AIDS diagnosis | |||
AIDS diagnosis | 1433 (36.4) | 876 (40.5) | 240 (39.3) |
HIV diagnosis | 2500 (63.6) | 1287 (59.5) | 371 (60.7) |
2013 ADAP plan | |||
PCIP | 399 (10.1) | 141 (6.5) | 26 (4.3) |
Direct ADAP | 3534 (89.9) | 2022 (93.5) | 585 (95.7) |
Financial status | |||
251%–400% FPL (tax credit) | 201 (5.1) | 138 (6.4) | 38 (6.2) |
139%–250% FPL (tax credit) | 677 (17.2) | 376 (17.4) | 76 (12.4) |
101%–138% FPL (Medicaid gap with tax credit) | 462 (11.7) | 285 (11.9) | 58 (9.5) |
<100% FPL (Medicaid gap, no Tax Credit) | 2593 (65.9) | 1391 (64.3) | 439 (71.8) |
Virginia region of residence | |||
Northwest | 339 (8.6) | 220 (10.2) | 52 (8.5) |
Eastern | 1379 (35.1) | 439 (20.3) | 191 (31.3) |
Central | 1011 (25.7) | 681 (31.5) | 195 (31.9) |
Southwest | 357 (9.1) | 236 (10.9) | 66 (10.8) |
Northern | 847 (21.5) | 587 (27.1) | 107 (17.5) |
CD4 cell count, mean (SD), cells/μL | 554 (322)c | 555 (319)d | 409 (295)e |
Time since HIV diagnosis, mean (SD), y | 9.2 (6.7)f | 9.6 (6.7)g | 9.5 (7.0)h |
Abbreviations: ADAP, AIDS Drug Assistance Program; FPL, federal poverty level; HIV, human immunodeficiency virus; PCIP, Pre-existing Condition Insurance Plan; SD, standard deviation.
a Cohort A includes people living with HIV who were 18–64 years old on 1 January 2013, were ADAP clients by 1 July 2013, did not receive Medicare, and had a Social Security number. Cohort B includes members of cohort A who demonstrated consistent engagement in care, as defined by ≥1 HIV viral load (VL) recorded in 2014 and ≥1 VL between 1 July 2014 and 31 December 2014. Cohort C includes members of cohort B who had an initial detectable VL in 2013, indicating suboptimally controlled HIV disease.
b Data represent No. (%) of patients, unless otherwise specified.
c Data available for 3684 subjects in cohort A.
d Data available for 2162 subjects in cohort B.
e Data available for 610 subjects in cohort C.
f Data available for 3381 subjects in cohort A.
g Data available for 1926 subjects in cohort B.
h Data available for 490 subjects in cohort C.